Therapy of T cell lymphomas with pentostatin

Annals of the New York Academy of Sciences

Volumn 941, Issue , 2001, Pages 200-205

  Kurzrock, Razelle ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Herpes zoster infection; Pentostatin

Indexed keywords

ADENOSINE DEAMINASE; CD4 ANTIGEN; PENTOSTATIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRANULOCYTOPENIA; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; KIDNEY FAILURE; MALE; NAUSEA; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA;

HERPES; HERPES ZOSTER;

EID: 0034809004     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03724.x     Document Type: Conference Paper

References (15)

1. A novel adenosine and ara-A deaminase inhibitor (R-3(2-deoxy-β-D-erythropentofuranosy10-3,6,7,8- tetrahydroimidozo(4,5-d)(1,3)-diazepin-8-ol
2. Deoxycoformycin in the treatment of mature T-cell leukaemias
3. Phase II trial of low dose 2-deoxycoformycin in refractory malignant lymphomas
4. An investigation of deoxycoformycin in advanced cutaneous T-cell lymphoma (CTCL)
5. Pentostatin (2′-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma
6. The role of pentostatin in the treatment of T-cell malignancies: Analysis of response rate in 145 patients according to disease subtype
7. Treatment of cutaneous T-cell lymphoma with 2′-deoxycoformycin (pentostatin)
8. Pentostatin (Nipent) in T-cell malignancies
9. Mycosis fungoides and Sézary syndrome
10. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
11. + lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: Seven year follow-up
12. Pentostatin therapy of T-cell lymphomas with cutaneous manifestations
13. Pentostatin: A review of its pharmaco-dynamic and pharmacokinetic properties, and therapeutic potential in lymhoproliferative disorders
14. Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin)
15. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′deoxycoformycin